July 25, 2024

The Quest to Save American-Made Antibiotics

by The Journal

USAntibiotics's plant in Tennessee is one of the last plants in the United States that makes amoxicillin, the crucial antibiotic that has been in shortage in some forms since 2022. But the plant isn’t breaking even, financially. WSJ’s Liz Essley Whyte reports on why it is so hard for American-made generic drugs manufacturers to survive.


Further Listening:

- Will Florida’s Plan to Get Cheap Drugs From Canada Work? 

- Trillion Dollar Shot 


Further Reading:

- Drug Shortages in America Reach a Record High 

- Drug Shortages Trigger FTC Probe 


Learn more about your ad choices. Visit megaphone.fm/adchoices

Where to Listen